Tempus AI Target of Unusually Large Options Trading (NASDAQ:TEM)

Tempus AI, Inc. (NASDAQ:TEM) saw some unusual options trading on Thursday. Investors acquired 11,239 call options on the stock. This represents an increase of 120% compared to the typical volume of 5,113 call options.

Wall Street Analyst Weigh In

Several research analysts have recently commented on TEM shares. Loop Capital lifted their target price on Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a research report on Tuesday, October 15th. Guggenheim started coverage on shares of Tempus AI in a report on Monday. They issued a “buy” rating and a $74.00 price objective for the company. Piper Sandler reissued a “neutral” rating and set a $70.00 target price (up from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Bank of America downgraded shares of Tempus AI from a “buy” rating to a “neutral” rating and raised their price target for the stock from $45.00 to $60.00 in a research report on Wednesday, October 2nd. Finally, Stifel Nicolaus downgraded shares of Tempus AI from a “buy” rating to a “hold” rating and boosted their price objective for the company from $45.00 to $65.00 in a research report on Monday, November 11th. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $56.20.

Tempus AI Trading Down 2.8 %

Shares of NASDAQ:TEM opened at $41.99 on Friday. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. The firm has a 50-day moving average price of $52.88. Tempus AI has a fifty-two week low of $22.89 and a fifty-two week high of $79.49.

Insider Activity

In related news, major shareholder Bradley A. Keywell sold 395,800 shares of the company’s stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $42.95, for a total value of $16,999,610.00. Following the sale, the insider now directly owns 16,164,449 shares of the company’s stock, valued at $694,263,084.55. This represents a 2.39 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Institutional Investors Weigh In On Tempus AI

Several large investors have recently made changes to their positions in the company. Kovitz Investment Group Partners LLC bought a new stake in shares of Tempus AI during the third quarter valued at about $1,367,000. Sumitomo Mitsui Trust Group Inc. increased its stake in Tempus AI by 1,591.2% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company’s stock valued at $68,922,000 after buying an additional 1,145,698 shares during the period. Captrust Financial Advisors bought a new stake in shares of Tempus AI during the 3rd quarter worth about $2,726,000. Sigma Planning Corp acquired a new stake in shares of Tempus AI in the 3rd quarter worth approximately $1,323,000. Finally, Dakota Wealth Management bought a new position in shares of Tempus AI in the third quarter valued at approximately $1,185,000. Institutional investors and hedge funds own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.